Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Financiere de Tubize
AddedFeb 20, 2024
UpdatedJul 22, 2026
Financiere de Tubize

Financiere de Tubize

Public

Financiere de Tubize SA, a pharmaceutical company, invests in and develops businesses across various sectors.

HQ
City of Brussels, Flemish Brabant, BE
Founded
1928
Overview
Compare
Employees
Website

Financiere de Tubize SA, founded with a core mission to invest in and develop businesses, operates primarily in the pharmaceutical sector. The company focuses on establishing, controlling, and transforming companies within the chemical, pharmaceutical, and film industries. Through strategic investments, Financiere de Tubize aims to foster innovation and growth in these sectors, contributing to advancements in healthcare and related fields.

Notable for its significant stake in UCB, a leading global biopharmaceutical company, Financiere de Tubize has played a crucial role in supporting pharmaceutical research and development. Its strategic investments have led to key achievements in the industry, enhancing its overall impact on healthcare innovation and market growth. The company’s influence extends through its robust investment portfolio, driving progress and transformation within its focus sectors.

Financiere de Tubize - Quick Facts

When was Financiere de Tubize founded?

Financiere de Tubize was founded in 1928.

Where is Financiere de Tubize's headquarters located?

Financiere de Tubize's headquarters is located in City of Brussels, Flemish Brabant, BE.

How many employees does Financiere de Tubize have?

Financiere de Tubize has 2 employees as of Feb 12, 2024.

Financiere de Tubize - Classification

Ownership
  • Private
Revenue
  • Investment
  • Transactional
Customer
  • Enterprise
Main Product
  • Investments
  • Pharmaceuticals
Tags
  • Biotech
  • Financial
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 6420Activities of holding companies
Show 2 more industry codes
SIC
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified